Our latest #4Sight eBook, "The medical affairs game changer," is now available at FirstWord Pharma. Our 4Sight approach is an insights journey for medical affairs enabled by artificial intelligence (AI) as a platform. It takes a holistic view, recognizing that even the most advanced tools are only as effective as the people and processes that support them. 🔍 In this eBook you’ll discover: 💡 The right platforms to harness AI effectively 💡 Streamlined processes that lead to exceptional outcomes 💡 Essential skills for building an AI-ready team Click here to download it: https://lnkd.in/eKcjF8bZ. #MedicalAffairs #AI #HealthcareInnovation #LifeSciences
Envision Pharma Group
Pharmaceutical Manufacturing
Smarter. faster outcomes for life sciences
About us
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 20 of the top 20 pharmaceutical companies. We have earned the reputation of a best-in-class partner for medical affairs teams, with expertise in leading medical strategy, medical communications, publication planning & delivery, patient engagement, and more. And through our comprehensive suite of services and industry-leading technology solutions - including Two Labs, Okra.ai, Riparian, and 90TEN - we support clients across the product life cycle. Clients come to us for expertise in artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Our purpose-built software, scientific solutions, and behavior change expertise make us a unique partner to the pharmaceutical industry.
- Website
-
http://www.envisionpharmagroup.com/
External link for Envision Pharma Group
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Global
- Type
- Privately Held
- Specialties
- Publication & Scientific Solutions, Technology Solutions, Grant management solutions, Market Access Solutions, Medical Communications Solutions, PR, Corporate Communications, Commercialisation, HEOR, Business Consulting & Strategic Solutions, Patient Communications, MSL Solutions, Document Collaboration, Strategic Consulting, Marketing Intelligence, Competitor Intelligence, Change Management, Operational Excellence, Publications Software, SaaS Solutions for Medical Affairs, Government Pricing, State Licensing, and Creative, Digital, Omnichannel
Locations
Employees at Envision Pharma Group
Updates
-
𝗜𝘁’𝘀 𝗴𝗼 𝘁𝗶𝗺𝗲 𝘄𝗶𝘁𝗵 𝗘𝗻𝘃𝗶𝘀𝗶𝗼𝗻𝗢𝗻𝗲 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀! Discover how this new solution enables smooth and efficient data movement across Envision technology solutions and multiple data sources. Delivering actionable insights to support clinical and commercial team success will become your superpower. 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗡𝗢𝗪 𝘁𝗼 𝗳𝗶𝗻𝗱 𝗼𝘂𝘁 𝗵𝗼𝘄! https://lnkd.in/g5uwpVm5 #MedicalAffairs #MedicalInformation #FutureOfHealth
-
What are the biggest roadblocks standing between patients and life-saving cell and gene therapies (CGTs)? How is AI revolutionizing cost models and transforming patient care in real time? In their latest blog, Kyle Felmet, VP of Specialty Commercialization, and Paul Archer, Chief Commercial Strategy Officer, provide critical insights into the high-stakes world of CGT commercialization. They uncover the rising tide of rare disease therapies, reveal the hidden costs of scaling these cutting-edge treatments, and outline the must-have strategies companies need to thrive in an ever-evolving market – https://lnkd.in/ePF8r7Sk #CellGeneTherapy #CGT #PharmaInnovation #LifeSciences #EnvisionPharmaGroup
-
As an AI-enabled leader in life sciences, Envision Pharma Group is proud to be part of FutureHealth Lausanne, the premier national conference uniting top innovators in the sector. In a time where digitalization and innovation are reshaping healthcare, this event gathers the foremost leaders to explore groundbreaking solutions for more accessible and efficient healthcare in the digital age. Today, Loubna Bouarfa, one of our esteemed keynote speakers, is delivering a talk on "Innovation for health: AI-driven healthcare outcomes for all." Together with leading life sciences experts, Loubna explores the transformative potential of these disruptive key technologies.
AI innovator | Founder OKRA.ai |Forbes 50 Top Women In Tech| MIT Innovator Under 35| EU AI High-Level Expert Group 2018 |SciTech CEO of Year 2019 | European Young Leader (EYL 40) 2022
Today, I was delighted to share my insights on "Innovation for Health: AI-Driven Healthcare Outcomes for All." at FutureHealth conference in Lausanne 🧬💡 🔷 Transforming Reactive Healthcare: Traditional approaches are often inefficient and costly, focusing more on symptoms than on underlying causes. AI's predictive capabilities can analyze vast amounts of health data, allowing us to forecast disease outbreaks and identify health risks early, reducing both time and costs. 🔷 Innovation Sandboxes: Creating controlled environments for testing new healthcare innovations is essential. Switzerland, with its innovative healthcare system, is the ideal hub for these sandboxes, allowing for safe experimentation and widespread benefits across Europe. 🔷 Future Vision: Imagine a proactive healthcare system driven by AI, utilizing continuous health monitoring and personalized treatment plans, demonstrating how collaboration can transform healthcare. At Envision Pharma Group, we’re transforming healthcare by leveraging AI to enhance collaboration and deliver smarter, faster patient outcomes that shape the future. 🚀 #FutureHealth2024 #FHL24 #AI #HealthcareInnovation #FutureHealth #HealthTech #health https://lnkd.in/ewhi42jz
-
Happy Birthday to 90TEN! As a part of Envision Pharma Group, 90TEN has been redefining healthcare communications and behavior change, delivering award-winning campaigns that inspire and make a real difference for patients, healthcare professionals, and communities. A huge thank you to the dedicated team at 90TEN for your unwavering passion and the incredible work you do every day. Your commitment to driving change and pushing the boundaries of what’s possible continues to elevate the entire Envision community. Here's to many more years of pushing boundaries and making an impact, together!
Happy birthday to us! 90TEN is 23! Not one to miss a chance for a bit of a get together, our birthday is also an opportunity for us to look back and take stock of everything we've achieved. A massive thank you to our team for all the amazing work you've delivered in the last 12 months! We continue to go from strength to strength while loving what we do. Here's to the next 23 years! #culture #healthcarecomms #medcomms
-
Envision Pharma Group reposted this
Publication bias presents an important opportunity for improvement in healthcare, particularly in enhancing the accuracy of systematic literature reviews (SLRs). In our latest blog, I explore how addressing publication bias can strengthen the evidence base, lead to more informed healthcare decisions and ensure better patient access to essential treatments. Want to learn more? Read the full blog to discover how to navigate the complexities of publication bias and enhance the credibility of your evidence base 👉 https://lnkd.in/eMANJVk6 #EvidenceBasedMedicine #SystematicReviews #Pharma #ValueAndAccess #MedicalWriting #ClinicalData #MarketAccess
-
One of our favorite moments from #Pharmageddon Europe 2024: Dr. Yahya Anvar and a remarkable panel of experts to taking on the challenge of data overload in pharma and how medical teams can leverage AI to overcome it. At Envision, we go beyond conventional solutions. As a technology-driven, AI-enabled service provider, we’re committed to delivering smarter, faster outcomes that leave a lasting impact and shape the future of healthcare. #PharmageddonEU #AIinPharma #Innovation #LifeSciences #GenerativeAI
-
Hello from #Pharmageddon Europe 2024! This week, Özge Özgüleryüz, Andrew Thompson, Yahya Anvar and Paul Archer are in Amsterdam collaborating with some of the boldest and most innovative thinkers from across the life sciences industry - like our friends Paul Simms and the Impatient Health team! Stay tuned for highlights. #PharmageddonEU #AIinPharma #Innovation #LifeSciences #GenerativeAI
-
Collaboration and strategy are the hallmarks of a successful medical affairs ecosystem, and that's what we designed the iEnvision platform to accomplish. Don't take our word for it; let the evidence speak for itself. Check out our recent case study to see how iEnvision supports a global pharmaceutical company's growing medical. affairs. https://lnkd.in/gDtEMsMg
-
The pharma industry is evolving, with patient perspectives rightfully gaining greater prominence. This shift is driven by the need for deeper patient insights to develop effective healthcare solutions. However, incorporating these diverse voices into value & access (V&A) strategies comes with challenges. In our latest article with Med Ad News, our Global Head of Commercial Strategy, Value & Access, Suki Kandola, explores: 💡 Empowering 'unheard' patient groups with unique insights 🌎 Navigating the evolving regulatory focus on patient-reported outcomes & real-world evidence 💪 Embracing patient-centricity to shape V&A strategies that truly resonate Learn more here: https://lnkd.in/gvBfv5hR #MarketAccess #Pharma #PatientAdvocacy
The changing engagement paradigm: elevating patient voices for better care - PharmaLive
https://www.pharmalive.com